A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

NCT04147325 · clinicaltrials.gov ↗

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

DRUG: Antiretroviral Therapy

Sponsor

Janssen-Cilag Farmaceutica Ltda.